Risk management considerations and advanced therapy medicinal products

被引:0
|
作者
Ruppert-Seipp, G. [1 ]
Muller, S. [1 ]
Berg, P. [1 ]
Funk, M. B. [1 ]
机构
[1] Paul Ehrlich Inst, Langen, Germany
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P636
引用
收藏
页码:A194 / A194
页数:1
相关论文
共 50 条
  • [41] Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges
    Diebold, Yolanda
    Garcia-Posadas, Laura
    PHARMACEUTICS, 2021, 13 (11)
  • [42] THE REGULATION OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE AND THE ROLE OF ACADEMIA
    Pearce, K. F.
    Hildebrandt, M. O.
    Scheding, S.
    Koehl, U.
    Mischak-Weissinger, E.
    Hauser, A.
    Edinger, M.
    Greinix, H.
    Worel, N.
    Apperley, J.
    Lowdell, M. W.
    Dickinson, A. M.
    CYTOTHERAPY, 2013, 15 (04) : S51 - S52
  • [43] The New Regulation of Advanced Therapy Medicinal Products in the European Union
    Ruiz, Sol
    MOLECULAR THERAPY, 2009, 17 : S395 - S395
  • [44] Payer and Implementation Challenges with Advanced Therapy Medicinal Products (ATMPs)
    John Spoors
    Alec Miners
    John Cairns
    Danny Palnoch
    Ash Summerfield
    Joanne McEntee
    Sheena Vithlani
    BioDrugs, 2021, 35 : 1 - 5
  • [45] Preclinical study for treatment of hypospadias by advanced therapy medicinal products
    V. Sceberras
    E. Attico
    E. Bianchi
    G. Galaverni
    M. Melonari
    F. Corradini
    M. Fantacci
    A. Ribbene
    L. Losi
    S. Balò
    M. Lazzeri
    C. Trombetta
    M. Rizzo
    R. Manfredini
    G. Barbagli
    G. Pellegrini
    World Journal of Urology, 2020, 38 : 2115 - 2122
  • [46] Editorial: Clinical Translation and Commercialisation of Advanced Therapy Medicinal Products
    Martin, Ivan
    Bayon, Yves
    Yu, Tracy T. L.
    Vertes, Alain A.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8 (08):
  • [47] Perspectives on approval and access to patients of Advanced Therapy Medicinal Products
    Pascual, M.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 : 120 - 121
  • [48] Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
    Cervo, Pia Rivetti di Val
    Alessi, Eva
    Lastella, Marilena
    La Greca, Antonio
    Trotta, Francesco
    BIODRUGS, 2024, 38 (06) : 831 - 844
  • [49] Payer and Implementation Challenges with Advanced Therapy Medicinal Products (ATMPs)
    Spoors, John
    Miners, Alec
    Cairns, John
    Palnoch, Danny
    Summerfield, Ash
    McEntee, Joanne
    Vithlani, Sheena
    BIODRUGS, 2021, 35 (01) : 1 - 5
  • [50] Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany
    Renner, Matthias
    Anliker, Brigitte
    Sanzenbacher, Ralf
    Schuele, Silke
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 87 - 101